💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Biogen Inc. (BIIB)
« Back to company indexBIIB Chatter Timeline
Stock Ticker for BIIB
Most Active Tweeters for BIIB
| User | Tweets |
|---|---|
| @bthefirsttoknow | 15 |
| @algobotnews | 9 |
| @UsMarketNews | 6 |
| @dailycandlestix | 6 |
| @TradingSin21 | 5 |
Recent Tweets for BIIB
 |
@Slayer10Stock $BIIB PCR by OI => 1.84, and Vol => 1.24 @ 2023-03-24. Learn more at https://t.co/e5urvrsvHr #BIIBSTOCK #trading https://t.co/iMaQ0TscOu 12:03am |
 |
@optioncharts $BIIB Implied Volatility expiration 03/24/2023 #maxpain #options https://t.co/00z7YyzluE https://t.co/QnMCztmjew March 21st 2023, 9:03pm |
 |
@dailycandlestix $BIIB Dark Cloud Cover Daily appearances since 2010: 52 Close 5 days later ±: Avg: -1.40 SD: 9.82 Worst: -33.54 Bes… https://t.co/OVhhP4p4Zd March 21st 2023, 8:03pm |
 |
@UsMarketNews $BIIB news Analysts positive on Biogen after FDA posts docs ahead of Advisory Panel for Tofersen March 21st 2023, 8:03pm |
 |
@SwingTradeBot 20 DMA Support today: $BIIB ... https://t.co/deOpbNqdR6 March 21st 2023, 8:03pm |
 |
@Beeken_health $BIIB $IONS - Wall Street predicts approval for another ALS drug https://t.co/1ERe5ShWfN March 21st 2023, 8:03pm |
 |
@BiopharmIQ $IONS & $BIIB Tofersen AdComm scheduled for tomorrow! Committee will vote on the clinical benefits & effectiveness… https://t.co/2X2J1kg6s5 March 21st 2023, 3:03pm |
 |
@BessieSantos17 $BIIB Real time stock analyses ratings and Target your prices https://t.co/GKnbNLrXYv March 21st 2023, 2:03pm |
 |
@algobotnews FDA briefing docs suggest FDA in favor of Biogen's tofersen, says BofA $BIIB March 21st 2023, 11:03am |
 |
@psk2329 Despite Failed Phase 3 Study, FDA Staff Says Biogens ALS Drug May Have Clinical Benefit $BIIB March 21st 2023, 11:03am |
 |
@CHItraders $BIIB Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit March 21st 2023, 10:03am |
 |
@bthefirsttoknow First out// $BIIB: Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit https://t.co/d5sbqQAv1r March 21st 2023, 10:03am |
 |
@TradingSin21 $BIIB Trading Ideas | Awaiting Short signal. 100% Profitability based on 2 trades. Profit factor is 100. Learn more… https://t.co/0nUWCVYgMR March 21st 2023, 10:03am |
 |
@Sonia0766255073 $biib **Top analyst price target for next week'> https://t.co/j23FHqa800 March 21st 2023, 8:03am |
 |
@STL_Biotech RT @NedPagliarulo: FDA staff assessment of $BIIB's ALS drug tofersen suggests agency's openness to using neurofilament light chain as a sur… March 21st 2023, 3:03am |
 |
@AltcoinGem Potential Cypher pattern developing on Biogen Inc. $BIIB. Projected price target 301 https://t.co/bDWzSMXZAe March 21st 2023, 12:03am |
 |
@MaisaCorp The U.S. health regulator's staff said on Monday safety issues with Biogen Inc's $BIIB drug to treat an ultra-rare… https://t.co/7aQDadKesu March 20th 2023, 11:03pm |
 |
@LisaLegacy4ALS RT @MaxGelman: FDA briefing documents on $BIIB tofersen are out. Quick skim indicates FDA is open to approval, and is asking the panel to a… March 20th 2023, 11:03pm |
|
@Beeken_health $BIIB - FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease https://t.co/jdEMUGVTPa March 20th 2023, 11:03pm |
 |
@auditor112017 @Sports_bios Looks like it is similar to SMA. The earlier the disease is treated, the better the outcome. $biib $ions March 20th 2023, 10:03pm |
 |
@BioPharmaDive FDA staff signal support for Biogen #ALS drug, but highlight data hurdles https://t.co/obc3SVWW4X $BIIB by @realJacobBell March 20th 2023, 9:03pm |
|
@BiopharmIQ $IONS & $BIIB AdComm for Tofersen to treat ALS scheduled for Wednesday 3/22! Briefing docs released today Previou… https://t.co/PLPpmf7VWD March 20th 2023, 9:03pm |
 |
@JustStocksToday RT @TopStockAlerts1: $BIIB FDA staff says Biogen’s ALS drug may have a ‘clinical benefit’ on a rare form of the disease https://t.co/UkMPb… March 20th 2023, 9:03pm |
 |
@TopStockAlerts1 $BIIB FDA staff says Biogen’s ALS drug may have a ‘clinical benefit’ on a rare form of the disease https://t.co/UkMPbK1oSw March 20th 2023, 9:03pm |
 |
@fwpharma FDA says Biogen drug may have benefit in genetic form of ALS despite mixed data $BIIB $AMLX https://t.co/nAnjLWTlqy March 20th 2023, 9:03pm |
 |
@StckPro $BIIB NEW ARTICLE : FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease… https://t.co/Gp0hm8hw9a March 20th 2023, 7:03pm |
 |
@matthewherper RT @ByMadeleineA: Good thread on tofersen briefing docs. Can't believe full approval is even being talked about as a possibility $BIIB $IONS March 20th 2023, 7:03pm |
 |
@ZG121015 $BIIB trying for a reversal on daily. https://t.co/OwTyuFyE9U March 20th 2023, 6:03pm |
 |
@IysLisa $BIIB Real time stock analyses ratings And target your prices https://t.co/Klk9LdNabN March 20th 2023, 6:03pm |
 |
@sleekoptions Peak profit for the last 6 expired option alerts for $BIIB 1.18% | 218.10% | 172.06% | -79.84% | 410.77% | 41.25% |… https://t.co/tbetro16mJ March 20th 2023, 6:03pm |
|
@sleekoptions $BIIB - Last six months, 1 option alerts peaked above 100% after they were triggered by the algo… https://t.co/vJ2XT23oNT March 20th 2023, 5:03pm |
 |
@LISAJON49296625 $BIIB Real Time stock analyses Ratings and target Your prices https://t.co/rehfeZSZBm March 20th 2023, 5:03pm |
|
@BiopharmIQ Briefing docs released for $BIIB and $IONS Tofersen AdComm (scheduled Wed 3/22) Committee will vote on if they bel… https://t.co/6u75Faj0jQ March 20th 2023, 5:03pm |
 |
@Loretta36000494 $BIIB Real Time stock analyses Ratings and target Your prices https://t.co/Wmy0krnEmY March 20th 2023, 5:03pm |
 |
@ShortAlgoKing $BIIB Trading Signals | Awaiting Short signal. 100% Win Rate based on 6 trades. Profit factor is 100. #stocks… https://t.co/4AjtormxlP March 20th 2023, 4:03pm |
 |
@YuZhu4 RT @RNAiAnalyst: $IONS $BIIB FDA making lots of excuses already for short-comings of #tofersen ALS data in the Briefing doc. Strongly expec… March 20th 2023, 4:03pm |
 |
@MaxGelman Story on $BIIB ALS briefing docs. The FDA will hold its advisory hearing Wednesday and decide on approval by April… https://t.co/FooPNBUtmd March 20th 2023, 4:03pm |
 |
@firsttradernews $BIIB FDA indicates willingness to approve Biogen ALS drug despite failed PhIII study https://t.co/oO82yUqFgW March 20th 2023, 3:03pm |
 |
@LongYield 2/ $BIIB Risks observed in trial patients, such as spinal cord inflammation and optic nerve swelling, are considere… https://t.co/zVkkQRo7C1 March 20th 2023, 3:03pm |
|
@LongYield 3/ $BIIB If approved under the accelerated approval pathway, tofersen will need to demonstrate clinical benefit in… https://t.co/t4OLzKICAd March 20th 2023, 3:03pm |
|
@LongYield 1/ $BIIB The FDA staff believes safety issues with Biogen's ALS drug, tofersen, should not prevent accelerated appr… https://t.co/9DzZnyKJRZ March 20th 2023, 3:03pm |
|
@biostockinfo RT @adamfeuerstein: $BIIB FDA briefing documents for Wednesday's Tofersen (ALS drug) adcomm are here: https://t.co/vf7bWbaKST March 20th 2023, 3:03pm |
 |
@evelyngreen1206 $BIIB Don't miss the Next move in a Few hours https://t.co/aM1JPUEHUE March 20th 2023, 2:03pm |
 |
@MarketCurrents $BIIB $IONS - FDA scientists weigh potential effect of Biogen ALS drug ahead of advisory meeting https://t.co/rw0FZdhq21 March 20th 2023, 2:03pm |
|
@TradingSin21 $BIIB Trading Ideas | Awaiting Short signal. 100% Profitability based on 6 trades. Profit factor is 100. Learn more… https://t.co/MiknkIBiId March 20th 2023, 2:03pm |
 |
@SparkNewswire $BIIB Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo https://t.co/dVpSsFd1rF March 20th 2023, 2:03pm |
 |
@FakeShkreli first pcns adcom without billy dunn, will be interesting to see what (if anything) buracchio contributes $ions $biib https://t.co/ebuOD5vEgn March 20th 2023, 2:03pm |
|
@bthefirsttoknow First out// $BIIB: Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo https://t.co/To5Oemv4d7 March 20th 2023, 2:03pm |
 |
@Trade_The_News $BIIB (US) FDA releases Tofersen briefing documents; Will discuss NDA, for tofersen (BIIB067) intrathecal injection… https://t.co/EVjivkFh1O March 20th 2023, 1:03pm |
 |
@newsfilterio FDA staff reviewers give the green light for $BIIB's drug for rare type of ALS or Lou Gehrig's disease. No new safe… https://t.co/1yjVPfzWQB March 20th 2023, 1:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.